Vulvovaginal-swab or first-catch urine specimen to detect Chlamydia trachomatis in women in a community setting?

Journal of Clinical Microbiology

Volumn 44, Issue 12, 2006, Pages 4389-4394

  Skidmore, Sue ^a   Horner, Paddy ^b,c   Herring, Alan ^a   Sell, Joanne ^a   Paul, Ian ^a   Thomas, Jane ^a   Caul, E Owen ^a   Egger, Matthias ^b,d   McCarthy, Anne ^b   Sanford, Emma ^b   Salisbury, Chris ^b   Macleod, John ^e   Sterne, Jonathan A C ^b   Low, Nicola ^b,d  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c UNIVERSITY HOSPITALS BRISTOL NHS FOUNDATION TRUST   (United Kingdom)

^d UNIVERSITY OF BERN   (Switzerland)

^e UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BACTERIUM DETECTION; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; COMMUNITY; CONTROLLED STUDY; DIAGNOSTIC KIT; ENZYME IMMUNOASSAY; FEMALE; FIRST CATCH URINE; HUMAN; MAJOR CLINICAL STUDY; MASS SCREENING; NEGATIVE GRAY ZONE TESTING; NONHUMAN; NUCLEIC ACID AMPLIFICATION; POLYMER CONJUGATE ENHANCED ENZYME IMMUNOASSAY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; STRAND DISPLACEMENT AMPLIFICATION; URINALYSIS; VAGINA SMEAR;

ADOLESCENT; ADULT; BACTERIOLOGICAL TECHNIQUES; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; NUCLEIC ACID AMPLIFICATION TECHNIQUES; SENSITIVITY AND SPECIFICITY; URINE; VAGINA; VULVA;

CHLAMYDIA; CHLAMYDIA TRACHOMATIS;

EID: 33845564663     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.01060-06     Document Type: Article

References (33)

1. Andersen, B., F. Olesen, J. K. Moller, and L. Ostergaard. 2002. Population-based strategies for outreach screening of urogenital Chlamydia trachomatis infections: a randomized, controlled trial. J. Infect. Dis. 185:252-258.
2. Carder, C., A. J. Robinson, C. Broughton, J. M. Stephenson, and G. L. Ridgway. 1999. Evaluation of self-taken samples for the presence of genital Chlamydia trachomatis infection in women using the ligase chain reaction assay. Int. J. STD AIDS 10:776-779.
3. Chan, E. L., K. Brandt, K. Olienus, N. Antonishyn, and G. B. Horsman. 2000. Performance characteristics of the Becton Dickinson ProbeTec System for direct detection of Chlamydia trachomatis and Neisseria gonorrhoeae in male and female urine specimens in comparison with the Roche Cobas System. Arch. Pathol. Lab. Med. 124:1649-1652.
4. Chernesky, M. A. 2002. Chlamydia trachomatis diagnostics. Sex. Transm. Infect. 78:232-234.
5. Chernesky, M. A., E. W. Hook III, D. H. Martin, J. Lane, R. Johnson, J. A. Jordan, D. Fuller, D. E. Willis, P. M. Fine, W. M. Janda, and J. Schachter. 2005. Women find it easy and prefer to collect their own vaginal swabs to diagnose Chlamydia trachomatis or Neisseria gonorrhoeae infections. Sex. Transm. Dis. 32:729-733.
6. Chernesky, M. A., D. Jang, K. Luinstra, S. Chong, M. Smieja, W. Cai, B. Hayhoe, E. Portillo, C. MacRitchie, C. Main, and R. Ewert. 2006. High analytical sensitivity and low rates of inhibition may contribute to detection of Chlamydia trachomatis in significantly more women by the APTIMA Combo 2 assay. J. Clin. Microbiol. 44:400-405.
7. Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases). 1999. National guideline for the management of Chlamydia trachomatis genital tract infection. Sex. Transm. Infect. 75(Suppl. 1):S4-S8. (Revised 2006.) http://www.bashh.org/ guidelines.asp. Accessed 6 November 2006.
8. Cosentino, L. A., D. V. Landers, and S. L. Hillier. 2003. Detection of Chlamydia trachomatis and Neisseria gonorrhoeae by strand displacement amplification and relevance of the amplification control for use with vaginal swab specimens. J. Clin. Microbiol. 41:3592-3596.
9. Dean, D., D. Ferrero, and M. McCarthy. 1998. Comparison of performance and cost-effectiveness of direct fluorescent-antibody, ligase chain reaction, and PCR assays for verification of chlamydial enzyme immunoassay results for populations with a low to moderate prevalence of Chlamydia trachomatis infection. J. Clin. Microbiol. 36:94-99.
10. Department of Health. 2001. Better prevention, better services, better sexual health-the national strategy for sexual health and HIV. Department of Health, London, United Kingdom. [Online.] http://www.dh.gov.uk/assetRoot/04/05/ 89/45/04058945.pdf.
11. Department of Health. 2006. The National Chlamydia Screening Programme (NCSP). Department of Health, London, United Kingdom. [Online.] http://www.dh.gov.uk/PolicyAndGuidance/HealthAndSocialCareTopics/SexualHealth/ SexualHealthGeneralInformation/SexualHealthGeneralArticle/fs/en?CONTENT_ID= 4084098&chk=CSLxsK.
12. Gaydos, C. A., K. A. Crotchfelt, N. Shah, M. Tennant, T. C. Quinn, J. C. Gaydos, K. T. McKee, Jr., and A. M. Rompalo. 2002. Evaluation of dry and wet transported intravaginal swabs in detection of Chlamydia trachomatis and Neisseria gonorrhoeae infections in female soldiers by PCR. J. Clin. Microbiol. 40:758-761.
13. Gaydos, C. A., K. Dwyer, M. Barnes, P. A. Rizzo-Price, B. J. Wood, T. Hemming, and T. Hogan. 2006. Internet-based screening for Chlamydia trachomatis to reach nonclinic populations with mailed self-administered vaginal swabs. Sex. Transm. Dis. 33:451-457.
14. Hjelm, E., A. Hallen, and M. Domeika. 2001. Cervical, urine and vaginal specimens for detection of Chlamydia trachomatis by ligase chain reaction in women: a comparison. Acta Dermato-Venereol. 81:285-288.
15. Horner, P., S. Skidmore, A. Herring, J. Sell, I. Paul, O. Caul, M. Egger, A. McCarthy, E. Sanford, C. Salisbury, J. MacLeod, J. Sterne, and N. Low for the Chlamydia Screening Studies (ClaSS) Group. 2005. Enhanced enzyme immunoassay with negative-gray-zone testing compared to a single nucleic acid amplification technique for community-based chlamydial screening of men. J. Clin. Microbiol. 43:2065-2069.
16. Johnson, R. E., T. A. Green, J. Schachter, R. B. Jones, E. W. Hook III, C. M. Black, D. H. Martin, M. E. St. Louis, and W. E. Stamm. 2000. Evaluation of nucleic acid amplification tests as reference tests for Chlamydia trachomatis infections in asymptomatic men. J. Clin. Microbiol. 38:4382-4386.
17. Johnson, R. E., W. J. Newhall, J. R. Papp, J. S. Knapp, C. M. Black, T. L. Gift, R. Steece, L. E. Markowitz, O. J. Devine, C. M. Walsh, S. Wang, D. C. Gunter, K. L. Irwin, S. DeLisle, and S. M. Berman. 2002. Screening tests to detect Chlamydia trachomatis and Neisseria gonorrhoeae infections-2002. Morb. Mortal. Wkly. Rep. Recomm. Rep. 51:1-38.
18. Low, N., A. McCarthy, J. Macleod, C. Salisbury, P. J. Horner, T. E. Roberts, R. Campbell, A. Herring, S. Skidmore, E. Sanford, J. A. C. Sterne, G. Davey Smith, A. Graham, M. Huengsberg, J. Ross, and M. Egger for the Chlamydia Screening Studies Group. 2004. The chlamydia screening studies: rationale and design. Sex. Transm. Infect. 80:342-348.
19. Low, N., A. McCarthy, J. Macleod, C. Salisbury, R. Campbell, T. E. Roberts, P. Horner, S. Skidmore, J. A. Sterne, E. Sanford, F. Ibrahim, A. Holloway, R. Patel, P. Barton, S. M. Robinson, N. Mills, A. Graham, A. Herring, E. O. Caul, G. Davey Smith, F. D. Hobbs, and M. Egger for the Chlamydia Screening Studies Group. Epidemiological, social, diagnostic, and economic evaluation of population screening for genital chlamydial infection: the Chlamydia Screening Studies project. Health Technol. Assess., in press.
20. Macleod, J., C. Salisbury, N. Low, A. McCarthy, J. A. Sterne, A. Holloway, R. Patel, E. Sanford, A. Morcom, P. Horner, S. G. Davey, S. Skidmore, A. Herring, O. Caul, F. D. Hobbs, and M. Egger. 2005. Coverage and uptake of systematic postal screening for genital Chlamydia trachomatis and prevalence of infection in the United Kingdom general population: cross sectional study. BMJ 330:940-942.
21. Macmillan, S., H. McKenzie, and A. Templeton. 2003. Parallel observation of four methods for screening women under 25 years of age for genital infection with Chlamydia trachomatis. Eur. J. Obstet. Gynecol. Reprod. Biol. 107:68-73.
22. Morré, S. A., I. G. M. Van Valkengoed, R. M. Moes, A. J. P. Boeke, C. J. L. M. Meijer, and A. J. C. Van den Brule. 1999. Determination of Chlamydia trachomatis prevalence in an asymptomatic screening population: performances of the LCx and COBAS Amplicor tests with urine specimens. J. Clin. Microbiol. 37:3092-3096.
23. Okadome, A., T. Notomi, S. Nomura, and A. Nagayama. 1999. Reactivity of a dual amplified chlamydia immunoassay with different serovars of Chlamydia trachomatis. Int. J. STD AIDS 10:460-463.
24. Schachter, J., M. A. Chernesky, D. E. Willis, P. M. Fine, D. H. Martin, D. Fuller, J. A. Jordan, W. Janda, and E. W. Hook III. 2005. Vaginal swabs are the specimens of choice when screening for Chlamydia trachomatis and Neisseria gonorrhoeae: results from a multicenter evaluation of the APTIMA assays for both infections. Sex. Transm. Dis. 32:725-728.
25. Schachter, J., W. M. McCormack, M. A. Chernesky, D. H. Martin, P. B. Van Der, P. A. Rice, E. W. Hook III, W. E. Stamm, T. C. Quinn, and J. M. Chow. 2003. Vaginal swabs are appropriate specimens for diagnosis of genital tract infection with Chlamydia trachomatis. J. Clin. Microbiol. 41:3784-3789.
26. Shafer, M. A., J. Moncada, C. B. Boyer, K. Betsinger, S. D. Flinn, and J. Schachter. 2003. Comparing first-void urine specimens, self-collected vaginal swabs, and endocervical specimens to detect Chlamydia trachomatis and Neisseria gonorrhoeae by a nucleic acid amplification test. J. Clin. Microbiol. 41:4395-4399.
27. Shrier, L. A., D. Dean, E. Klein, K. Harter, and P. A. Rice. 2004. Limitations of screening tests for the detection of Chlamydia trachomatis in asymptomatic adolescent and young adult women. Am. J. Obstet. Gynecol. 190:654-662.
28. Skidmore, S., P. Horner, and H. Mallinson on behalf of the HPA Chlamydia Diagnosis Forum. 2006. Testing specimens for Chlamydia trachomatis. Sex. Transm. Infect. 82:272-275.
29. Tanaka, M., H. Nakayama, K. Sagiyama, M. Haraoka, H. Yoshida, T. Hagiwara, K. Akazawa, and S. Naito. 2000. Evaluation of a new amplified enzyme immunoassay (EIA) for the detection of Chlamydia trachomatis in male urine, female endocervical swab, and patient obtained vaginal swab specimens. J. Clin. Pathol. 53:350-354.
30. Tanaka, M., H. Nakayama, H. Yoshida, K. Takahashi, T. Nagafuji, T. Hagiwara, and J. Kumazawa. 1998. Detection of Chlamydia trachomatis in vaginal specimens from female commercial sex workers using a new improved enzyme immunoassay. Sex. Transm. Infect. 74:435-438.
31. Tong, C. Y., C. Donnelly, and N. Hood. 1997. Lowering the cut off value of an automated chlamydia enzyme immunoassay and confirmation by PCR and direct immunofluorescent antibody test. J. Clin. Pathol. 50:681-685.
32. van Bergen, J., H. M. Gotz, J. H. Richardus, C. J. Hoebe, J. Broer, A. J. Coenen, and the PILOT CT Study Group. 2005. Prevalence of urogenital Chlamydia trachomatis increases significantly with level of urbanisation and suggests targeted screening approaches: results from the first national population based study in The Netherlands. Sex. Transm. Infect. 81:17-23.
33. Wiesenfeld, H. C., R. P. Heine, A. Rideout, I. Macio, F. DiBiasi, and R. L. Sweet. 1996. The vaginal introitus: a novel site for Chlamydia trachomatis testing in women. Am. J. Obstet. Gynecol. 174:1542-1546.